Cellectar Biosciences, Inc. (CLRB) Financials
CLRB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 21.6 million | 34.9 million |
2023-06-30 | 6.5 million | 7.0 million |
2023-03-31 | 14.8 million | 7.5 million |
2022-12-31 | 21.6 million | 6.1 million |
CLRB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -8.7 million | 497878 |
2023-06-30 | -7.5 million | 419757 |
2023-03-31 | -7.2 million | 408206 |
2022-12-31 | -7.5 million | 361447 |
CLRB Net Income
No data available :(
CLRB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 19.0 million | - | 569013 |
2023-06-30 | 5.2 million | - | 584496 |
2023-03-31 | 12.7 million | - | 599450 |
2022-12-31 | 19.9 million | - | 603828 |
CLRB Shares Outstanding
CLRB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 597282 | 7.3 million | 2.1 million | - |
2023-06-30 | - | 6.3 million | 2.0 million | - |
2023-03-31 | - | 6.7 million | 2.1 million | - |
2022-12-31 | 117856 | 5.5 million | 2.0 million | - |
CLRB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 55942 |
2023-06-30 | - | 52855 |
2023-03-31 | - | 56386 |
2022-12-31 | - | 62044 |
CLRB
Price: $3.42
52 week price:
Earnings Per Share: -3.11 USD
P/E Ratio: -1.07
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 27300
Ebitda: -3.4 millionMarket Capitalization: 119.7 million